IRIS Accounts Production v25.1.4.42 04551378 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh045513782023-10-31045513782024-10-31045513782023-11-012024-10-31045513782022-10-31045513782022-11-012023-10-31045513782023-10-3104551378ns15:EnglandWales2023-11-012024-10-3104551378ns14:PoundSterling2023-11-012024-10-3104551378ns10:Director12023-11-012024-10-3104551378ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3104551378ns10:SmallEntities2023-11-012024-10-3104551378ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3104551378ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3104551378ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3104551378ns10:FullAccounts2023-11-012024-10-310455137812023-11-012024-10-3104551378ns10:Director22023-11-012024-10-3104551378ns10:RegisteredOffice2023-11-012024-10-3104551378ns5:CurrentFinancialInstruments2024-10-3104551378ns5:CurrentFinancialInstruments2023-10-3104551378ns5:ShareCapital2024-10-3104551378ns5:ShareCapital2023-10-3104551378ns5:RetainedEarningsAccumulatedLosses2024-10-3104551378ns5:RetainedEarningsAccumulatedLosses2023-10-3104551378ns5:NetGoodwill2023-11-012024-10-3104551378ns5:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3104551378ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-11-012024-10-3104551378ns5:FurnitureFittings2023-11-012024-10-3104551378ns5:NetGoodwill2023-10-3104551378ns5:NetGoodwill2024-10-3104551378ns5:NetGoodwill2023-10-3104551378ns5:LandBuildings2023-10-3104551378ns5:FurnitureFittings2023-10-3104551378ns5:LandBuildings2023-11-012024-10-3104551378ns5:LandBuildings2024-10-3104551378ns5:FurnitureFittings2024-10-3104551378ns5:LandBuildings2023-10-3104551378ns5:FurnitureFittings2023-10-3104551378ns5:CostValuation2023-10-3104551378ns5:AdditionsToInvestments2024-10-3104551378ns5:CostValuation2024-10-3104551378ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3104551378ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-31
















Ashcroft Pharmacy Ltd

Financial Statements for the Year Ended 31 October 2024






Ashcroft Pharmacy Ltd (Registered number: 04551378)






Contents of the Financial Statements
for the year ended 31 October 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Ashcroft Pharmacy Ltd

Company Information
for the year ended 31 October 2024







DIRECTORS: Mrs W K Hussain
Dr K K Hussain





REGISTERED OFFICE: 45 Ashcroft Road
Stopsley
Luton
Bedfordshire
LU2 9AU





REGISTERED NUMBER: 04551378 (England and Wales)





ACCOUNTANTS: Hargreaves Owen Ltd
Chartered Certified Accountants
Red Sky House
Fairclough Hall, Halls Green
Weston
Hertfordshire
SG4 7DP

Ashcroft Pharmacy Ltd (Registered number: 04551378)

Balance Sheet
31 October 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1 1
Tangible assets 5 32,638 36,813
Investments 6 440,000 190,000
472,639 226,814

CURRENT ASSETS
Stocks 17,000 16,500
Debtors 7 223,981 289,151
Cash at bank and in hand 485,812 538,596
726,793 844,247
CREDITORS
Amounts falling due within one year 8 236,071 215,945
NET CURRENT ASSETS 490,722 628,302
TOTAL ASSETS LESS CURRENT
LIABILITIES

963,361

855,116

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 963,359 855,114
SHAREHOLDERS' FUNDS 963,361 855,116

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Ashcroft Pharmacy Ltd (Registered number: 04551378)

Balance Sheet - continued
31 October 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 February 2025 and were signed on its behalf by:





Dr K K Hussain - Director


Ashcroft Pharmacy Ltd (Registered number: 04551378)

Notes to the Financial Statements
for the year ended 31 October 2024

1. STATUTORY INFORMATION

Ashcroft Pharmacy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - straight line over 30 years
Fixtures and fittings - 15% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 9 ) .

Ashcroft Pharmacy Ltd (Registered number: 04551378)

Notes to the Financial Statements - continued
for the year ended 31 October 2024

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 November 2023
and 31 October 2024 119,999
AMORTISATION
At 1 November 2023
and 31 October 2024 119,998
NET BOOK VALUE
At 31 October 2024 1
At 31 October 2023 1

5. TANGIBLE FIXED ASSETS
Fixtures
Freehold and
property fittings Totals
£    £    £   
COST
At 1 November 2023
and 31 October 2024 119,995 22,516 142,511
DEPRECIATION
At 1 November 2023 84,000 21,698 105,698
Charge for year 4,000 175 4,175
At 31 October 2024 88,000 21,873 109,873
NET BOOK VALUE
At 31 October 2024 31,995 643 32,638
At 31 October 2023 35,995 818 36,813

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 November 2023 190,000
Additions 250,000
At 31 October 2024 440,000
NET BOOK VALUE
At 31 October 2024 440,000
At 31 October 2023 190,000

Ashcroft Pharmacy Ltd (Registered number: 04551378)

Notes to the Financial Statements - continued
for the year ended 31 October 2024

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 135,062 181,012
Other debtors 52,806 75,806
VAT 33,865 32,333
Prepayments 2,248 -
223,981 289,151

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 164,779 100,922
Corporation tax 60,807 29,327
PAYE 181 (446 )
Directors Current Account 1,627 78,228
Net wages 7,219 7,239
Accrued expenses 1,458 675
236,071 215,945